Skip to main content

SUBLOCADE Long-term Outcomes

Completed · NCT05860959

Conditions: Opioid Use Disorder

At a glance

Research payments reported, 2025
$590,190
U.S. investigators named
30
Sites paid
32
Planned or actual enrollment
480

About the trial

Sponsor
Indivior Inc.
Dates
Started 2023-08-31; completion 2025-08-31
Results posted
Not yet

This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.

From ClinicalTrials.gov, last updated 2026-11-05. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Indivior Inc. reported $590,190 in research payments for this study in 2025 (1,752 payments).

Products named: Sublocade

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.